USA & Canada Cervical Cancer Diagnostic Market, Patients by Test Type (Pap Smear, HPV DNA), in North America
- Report Description Table of Contents
Cervical cancer is the fourth most common cancer prevailing in women and the seventh in terms of overall cancer incidences. North America Cervical Cancer Screening Market is projected to reach US$ 100 Million by the year 2024. Cervical cancer affects the lower part of the uterus (womb). Cervical cancer generally occurs in women over 30 years. It is mostly caused by the Human papillomavirus (HPV) virus.
Increasing cervical cancer prevalence rate is one of the key factors that drive the cervical cancer screening market. Rapidly increasing female population, growing incidence of HPV infections and increasing awareness about cervical cancer screening programs is also expected to drive the cervical cancer screening market in the near future.
The report titled “USA & Canada Cervical Cancer Diagnostic Market, Patients by Test Type (Pap Smear, HPV DNA), in North America” provides a complete analysis of North America Cervical Cancer Screening Market. The report provides a complete analysis of North America Cervical Cancer Test Market, Screened Population & Mortality.
By Test Types – Pap smear Screening Tests is gaining popularity in North America
The report studies the market and population of the following cervical cancer screening tests: Pap smear Tests and HPV DNA Tests. Pap smear and HPV DNA tests are more popular with the developed countries such as United States.
By Country – United State has bright future in Cervical Cancer Screening Market in near future
The report studies the market/screened population of two big North America’s country (United State and Canada) which provides a complete country-wise analysis of North America Cervical Cancer Screening Market, Population and Mortality.
Cervical Cancer Diagnostic Market & Population
- Pap Smear Tests Market
- HPV DNA Tests Market
Cervical Cancer Mortality Population
- United State